Skip to main content

New Antibiotic Targets

  • Book
  • © 2008

Overview

  • Features novel drug targets including peptide deformylase, ribosome formation, lipopolysaccharide and fatty acid biosynthesis and signal transduction pathways.
  • Includes new methods for the assay of RNA polymerase, peptide bond formation, translational initiation, ribosome biogenesis and membrane permeability, as well as methods for target identification by bacterial genome searches
  • Details the activity of novel inhibitors of DNA polymerase, peptide deformylase, membrane transport, efflux pumps and beta-lactamases

Part of the book series: Methods in Molecular Medicine (MIMM, volume 142)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 protocols)

Keywords

About this book

A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In “New Antibiotic Targets,” W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies.

“New Antibiotic Targets” provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases.

Reviews

From the reviews:

"This book describes, in specific detail, a variety of methods used to identify cellular components of bacteria that would be good targets for antibiotics. … Those working in laboratories on discovery of new antibiotics are the intended audience. The book is easy to follow and written in a step-wise fashion. It would be easy for laboratory technicians as well as graduate students to follow. … This is a good methods book that contains the latest information on new techniques." (Rebecca T. Horvat, Doody’s Review Service, May, 2008)

"The contributors to each chapter are good and well known names in their fields, providing good coverage of their subjects. I think this book will find utility in the field of drug discovery and target identification specifically from compound libraries … ." (Paul Hoskisson, Microbiology Today, July, 2008)

Editors and Affiliations

  • Department of Biochemistry and Molecular Biology, East Tennessee State University, Johnson

    W. Scott Champney

Bibliographic Information

  • Book Title: New Antibiotic Targets

  • Editors: W. Scott Champney

  • Series Title: Methods in Molecular Medicine

  • DOI: https://doi.org/10.1007/978-1-59745-246-5

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Protocols

  • Copyright Information: Humana Press 2008

  • Hardcover ISBN: 978-1-58829-915-4Published: 15 January 2008

  • Softcover ISBN: 978-1-61737-843-0Published: 10 November 2010

  • eBook ISBN: 978-1-59745-246-5Published: 01 February 2008

  • Series ISSN: 1543-1894

  • Series E-ISSN: 1940-6037

  • Edition Number: 1

  • Number of Pages: XII, 274

  • Number of Illustrations: 51 b/w illustrations

  • Topics: Infectious Diseases, Immunology, Molecular Medicine, Virology

Publish with us